were recruited into this study. In addition to meeting NOTT arterial blood gas criteria, entry criteria for our study included the following: the ability to give informed consent (the study protocol was approved by the Research and Development Committee and the Subcommittee on Human Studies of our VAMC), at least 6 months of prior HOT use so as to ensure stability, and the absence of any illness expected to result in shortened survival, eg, cancer. Ultimately, 24 patients were randomized into the 2-month follow-up group and 26 patients were randomized into the 6-month group. In addition to prescribing resting oxygen flow rates according to arterial blood gas measurements, we prescribe patient specific oxygen flow rates for activity in which flows are increased during a 12-min walk with continuous pulse oximetric monitoring, to a level that provides an arterial saturation of greater than 90%. Nocturnal flow rates are set at the same value as resting flow rates. Patients are similarly evaluated by resting arterial blood gas and exercise pulse oximetry at the 2-or 6-month follow-up intervals to which they were randomized. All home oxygen is provided by a single contractor, awarded on the basis of competitive bidding. Ambulatory liquid oxygen systems are used except when the patient is housebound.
Data Collection
Baseline evaluation included an extensive demographic questionnaire, pulmonary function testing, arterial blood gas analysis, pulse oximetry, visual analogue scale for dyspnea (VAS),34 sickness impact profile (SIP),5,6 and exercise tolerance as measured by a 12-min walk.7 Data were collected by an experienced research nurse. These parameters, with the exception of the demographic questionnaire, were also obtained at each 2-or 6-month reevaluation. In addition, all patients were asked to maintain a logbook for all healthcare contacts and days of illness. Finally, each subject was contacted by telephone every 2 weeks by nonmedical office personnel who used a standardized script in which patients were questioned about the following: symptoms; illness; healthcare provider contacts; office, hospital, or emergency department visits; and medication changes. By design, this individual was not able to answer any healthcare questions, which were referred to either the study nurse or the primary physician. Oxygen usage and costs were provided monthly by our contractor. Other costs were determined using standard VAMC charges, provided by our Fiscal Service. For health visits made outside the VAMC, actual bills, as well as "usual and customary charges" of Blue Cross and Blue Shield were obtained.
Statistics
The statistical analyses were performed under the supervision of a biostatistician using a statistical package (STATISTIX 3.0) on a microcomputer (386DX). Parametric (Student's t), reciprocally transformed parametric, and nonparametric (Mann-Whitney Rank Sum) analyses were used. Corrections for multiple comparisons were applied where appropriate.
RESULTS
Except for a paucity of female patients, our population would seem to be quite comparable to the NOTT group (Table 2 ). In our study, the "all cause" 1-year mortality was 16%. Although 21 (42%) of our subjects had no hospitalizations in the study period, 9 (18%) had three or more hospitalizations (the vast majority of which were related to respiratory problems). The mean number of hospital days per year for those patients requiring hospital admission was 17. The study population had a significant degree of chronic illness, with a mean overall SIP score of 22.
Comparison of Study Group Outcomes
There were no statistically significant differences in any of the measured baseline parameters between the 2-and 6-month groups ( Table 3 ), suggesting that randomization was adequate.
When the 2-and 6-month groups were compared with each other at 1-year follow-up, there were no statistically significant differences in the clinical outcome parameters measured (Table 4) . We then looked at the 12-month change for each individual clinical outcome parameter from baseline (Table 3) to 1-year follow-up (Table 4) for the 6-month group using a paired t test, and found no statistically significant changes. When we did the same for the 2-month group, we found a significant change only in the SIP score that improved from 20.7 ± 15.4 to 19.2 ±16.0 (p=0.0027) over the 12-month period. When the SIP scores were broken down into subscores, it was found that only the psychosocial subscore showed a significant improvement (p= 0.0198); the physical subscore did not (p=0.0784).
Although we had postulated that more frequent reevaluation of oxygen needs might reduce physician visits, emergency department visits, and hospitalizations, this was not the case. In fact there were no differences in any of the outcome parameters save for the expected difference in evaluation costs (Table 4) Although the difference in total costs was not significant between the groups, there was a significant difference (p<0.001) in evaluation costs. The more frequent reevaluation of the 2-month group resulted in an excess cost of $204 per patient per year compared with that of the 6-month group. The large, though nonsignificant, differences in hospital days and hospital costs between the two groups were largely due to four patients in the 6-month group with very extended hospital stays.
DIscuSSION
The only statistically significant clinical outcome difference that we discovered between the 2-and 6-month groups involved the SIP where there was a significant improvement in the 2-month group, but not in the 6-month group when baseline values were compared with those at 1-year follow-up. This improvement was solely attributable to an improvement in the psychosocial subscore. The importance of this finding is unclear. It may be attributed to chance or it may reflect true psychologic benefit from more frequent health care. We were unable to show any other clinical outcome differences between the two groups.
Our overall SIP score of 22 is similar to those of the NOTT study8 and the "high emergent" group described by Traver.9 It is higher, indicating greater 11, 580 illness, than reported in the Seattle-King County home care study (overall SIP score of 16) and exceeds those observed for the population receiving longterm hemodialysis.1011
Our findings have important implications for both patient safety and health-care costs. From the perspective of health-care reimbursement agencies, HOT is significant both in size and expense. Although no accurate figures for the number of individuals in this country who currently receive HOT exist, estimates range from 500,000 to 800,000.12 In a similar fashion to dialysis and other expensive therapeutic modalities, HOT has been given special status by the federal government, which supports payments for home oxygen through HCFA. Clearly, in a program of this size there is the potential for both intentional and unintentional abuse.'134 These concerns have resulted in recent HCFA decisions to try to more closely control the costs of this therapy. This has led to strict guidelines for the prescription of oxygen (codification of the original NOTT criteria as Medicare rules) and cost control measures that may limit patient access to liquid oxygen and oxygen-conserving devices.'156 Unfortunately, a scientific basis for these decisions does not exist. Clearly, many individuals who originally meet the NOTT criteria and who receive maximum medical therapy, will have conditions that improve to the point that they are no longer candidates for continuous oxygen. This may occur in as many as 40% of patients originally referred for oxygen therapy during an acute illness.17",8 Extrapolating the added evaluation costs for 2-month follow-up found in this study to the nation as a whole would result in excess costs of at least $60 million per year.
One potential limitation of our study was that we did not monitor patient compliance. Although all patients were instructed to use oxygen 24 h/d, such strict compliance cannot be guaranteed. In addition, it is possible that the patients in the 2-month group may have received more frequent encouragement to remain compliant, which could theoretically lead to a better clinical outcome in that group of patients.
Although concentrator usage or liquid oxygen delivery is easily measured, these values reflect equipment "Con-time" and frequently do not reflect actual oxygen use by the patient. We are currently working to develop methods to measure and improve patient compliance.
A second potential limitation is found in the small number of patients in our study, which could lead to a type IL error. In particular, we cannot be sure that differences between the two study groups would not become significant if a larger cohort of patients were studied, and we would recommend that such a follow-up study be performed.
Overall, we were unable to show an advantage to more frequent follow-up of patients receiving HOT and believe that our data support the recommendation that routine reevaluation of patients receiving HOT need not be performed more often than every 6 months. However, given the limited number of patients enrolled in our study, we cannot absolutely exclude the possibility that a minor advantage for 2-month follow-up may have been found if a larger population of patients were studied.
